| P50 | author | Ewa Marcinkowska | Q57561431 |
| P2093 | author name string | Geoffrey Brown | |
| P2860 | cites work | The epigenetic landscape of acute myeloid leukemia | Q21284742 |
| | Human FLT3/FLK2 gene: cDNA cloning and expression in hematopoietic cells | Q24316878 |
| | Acute myeloid leukemia in the older adults | Q26740584 |
| | Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group | Q58416097 |
| | How I treat pediatric acute myeloid leukemia | Q26992280 |
| | Challenge of cancer in the elderly | Q28069040 |
| | Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML | Q28118823 |
| | The World Health Organization (WHO) classification of the myeloid neoplasms | Q28202501 |
| | Acute Myeloid Leukemia | Q28267442 |
| | Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group | Q28296408 |
| | Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group | Q31163049 |
| | Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: a phase III trial (E2995) | Q33758413 |
| | The Cytokine Flt3-Ligand in Normal and Malignant Hematopoiesis | Q33838356 |
| | Diverse Regulation of Vitamin D Receptor Gene Expression by 1,25-Dihydroxyvitamin D and ATRA in Murine and Human Blood Cells at Early Stages of Their Differentiation | Q33839179 |
| | Acute myeloid leukemia, version 2.2013. | Q34165330 |
| | Acute myeloid leukaemia in adults | Q34327218 |
| | Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. A study on a large series of patients and cell lines | Q34441541 |
| | The treatment of acute myeloid leukemia in first relapse: a comprehensive review of the literature | Q35103330 |
| | T315 Decreases Acute Myeloid Leukemia Cell Viability through a Combination of Apoptosis Induction and Autophagic Cell Death | Q37210190 |
| | Acute myeloid leukaemia in the elderly: a review | Q37840260 |
| | Current standard treatment of adult acute promyelocytic leukaemia | Q38674575 |
| | Semi-Quantitative Mass Spectrometry in AML Cells Identifies New Non-Genomic Targets of the EZH2 Methyltransferase. | Q38698037 |
| | Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study. | Q38831810 |
| | A Case of AML Characterized by a Novel t(4;15)(q31;q22) Translocation That Confers a Growth-Stimulatory Response to Retinoid-Based Therapy | Q41182592 |
| | Clinical Outcomes and Co-Occurring Mutations in Patients with RUNX1-Mutated Acute Myeloid Leukemia | Q41573002 |
| | Immunotherapeutic Concepts to Target Acute Myeloid Leukemia: Focusing on the Role of Monoclonal Antibodies, Hypomethylating Agents and the Leukemic Microenvironment | Q41573313 |
| | Selective Expression of Flt3 within the Mouse Hematopoietic Stem Cell Compartment. | Q42229089 |
| | Apoptosis Induced by the Curcumin Analogue EF-24 Is Neither Mediated by Oxidative Stress-Related Mechanisms nor Affected by Expression of Main Drug Transporters ABCB1 and ABCG2 in Human Leukemia Cells. | Q46271548 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | leukemia | Q29496 |
| P577 | publication date | 2017-11-30 | |
| P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
| P1476 | title | Acute Myeloid Leukaemia: New Targets and Therapies | |
| P478 | volume | 18 | |